| Amanda Woolverton, RN | |
|
498 Chalan Palosyo, Agana Heights, GU 96910-6427 | |
| (671) 475-5761 | |
| Not Available |
| Full Name | Amanda Woolverton |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 498 Chalan Palosyo, Agana Heights, Guam |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558112011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RE3481 (Guam) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Woolverton, RN 498 Chalan Palosyo, Agana Heights, GU 96910-6427 Ph: () - | Amanda Woolverton, RN 498 Chalan Palosyo, Agana Heights, GU 96910-6427 Ph: (671) 475-5761 |
News Archive
Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.
A University of Arizona College of Medicine - Phoenix researcher has received a $393,493 grant from the National Institutes of Health to further her research in reducing the risk of heart failure in patients with high blood pressure.
A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry and EGEN, Inc., a privately held biopharmaceutical company focused on developing nucleic acid (DNA and RNAi) therapeutics for the treatment of human diseases, are pleased to announce they have executed a continuation of their feasibility collaboration focused on long-term controlled release of siRNA complexes.
› Verified 2 days ago
Rosewynda De San Jose Santos, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-475-5760 | |
Mr. Eliot Spencer, CRNA, MSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Bldg #1 Farenholt Rd, U.s. Naval Hospital Guam, Agana Heights, GU 96910 Phone: 671-344-9340 | |
Maryann Lumba Dizon, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-475-5760 | |
Daisy Rose Leones Baisa, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo Bldg 22, Agana Heights, GU 96910 Phone: 671-475-5847 | |
Mr. Kyle Custodio Arevalo, MSN/ED, RN, AMB-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-475-5794 Fax: 808-433-7756 | |
Dr. Milena Anezka Marshall, DNP, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: U.s. Naval Hospital Guam, Bldg 50, Farenholt Avenue, Agana Heights, GU 96910 Phone: 671-344-9340 |